Chiara Lazzari

2.5k total citations
67 papers, 1.5k citations indexed

About

Chiara Lazzari is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Chiara Lazzari has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 43 papers in Pulmonary and Respiratory Medicine and 22 papers in Molecular Biology. Recurrent topics in Chiara Lazzari's work include Lung Cancer Treatments and Mutations (37 papers), Lung Cancer Research Studies (24 papers) and Cancer Genomics and Diagnostics (11 papers). Chiara Lazzari is often cited by papers focused on Lung Cancer Treatments and Mutations (37 papers), Lung Cancer Research Studies (24 papers) and Cancer Genomics and Diagnostics (11 papers). Chiara Lazzari collaborates with scholars based in Italy, Spain and United States. Chiara Lazzari's co-authors include Vanesa Gregorc, Rafael Rosell, Niki Karachaliou, Mariacarmela Santarpía, Alessandra Bulotta, Filippo de Marinis, Gianluca Spitaleri, Giuseppe Altavilla, Silvia Soddu and Luca Gianni and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Chiara Lazzari

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chiara Lazzari Italy	24	883	738	580	313	127	67	1.5k
Monica Ganzinelli Italy	23	1.2k 1.4×	908 1.2×	710 1.2×	309 1.0×	118 0.9×	83	1.9k
Soji Kakiuchi Japan	21	850 1.0×	910 1.2×	998 1.7×	313 1.0×	153 1.2×	41	1.9k
Gonzalo Recondo United States	15	637 0.7×	576 0.8×	386 0.7×	313 1.0×	103 0.8×	54	1.1k
Tindara Franchina Italy	19	749 0.8×	633 0.9×	487 0.8×	311 1.0×	98 0.8×	60	1.3k
Dana T. Aftab United States	20	882 1.0×	574 0.8×	803 1.4×	417 1.3×	156 1.2×	45	1.8k
Erzsébet Juhász Hungary	15	1.2k 1.3×	1.1k 1.4×	568 1.0×	235 0.8×	201 1.6×	28	1.7k
Remy B. Verheijen Netherlands	18	630 0.7×	794 1.1×	542 0.9×	182 0.6×	95 0.7×	50	1.4k
Rintaro Noro Japan	25	697 0.8×	811 1.1×	978 1.7×	531 1.7×	83 0.7×	95	1.8k
Lone H. Ottesen United States	18	618 0.7×	698 0.9×	646 1.1×	214 0.7×	84 0.7×	56	1.4k
Jeremy Cetnar United States	14	905 1.0×	788 1.1×	372 0.6×	233 0.7×	171 1.3×	42	1.4k

Countries citing papers authored by Chiara Lazzari

Since Specialization

Citations

This map shows the geographic impact of Chiara Lazzari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Lazzari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Lazzari more than expected).

Fields of papers citing papers by Chiara Lazzari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Lazzari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Lazzari. The network helps show where Chiara Lazzari may publish in the future.

Co-authorship network of co-authors of Chiara Lazzari

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Lazzari. A scholar is included among the top collaborators of Chiara Lazzari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Lazzari. Chiara Lazzari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bartolini, Alice, Daniela Cantarella, Annamaria Gullà, et al.. (2024). Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model. International Journal of Molecular Sciences. 25(20). 11228–11228.

Porcu, Luca, Leone Giordano, Stefano Cascinu, et al.. (2023). Emergency Department Visits among Cancer Patients during SARS-CoV-2 Pandemic. Cancers. 15(4). 1240–1240.

Pecciarini, Lorenza, Emanuela Brunetto, Greta Grassini, et al.. (2023). Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?. Cells. 12(8). 1135–1135. 12 indexed citations

Lazzari, Chiara, et al.. (2023). Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives. Current Oncology. 30(4). 3684–3696. 22 indexed citations

Giovannetti, Elisa, et al.. (2023). Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?. International Journal of Molecular Sciences. 24(12). 10119–10119. 16 indexed citations

Campochiaro, Corrado, Nicola Farina, Alessandro Tomelleri, et al.. (2022). Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors. European Journal of Internal Medicine. 103. 95–99. 8 indexed citations

Gagliardi, Filippo, Silvia Snider, Lina Raffaella Barzaghi, et al.. (2021). Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: A systematic review on current evidences and predicting factors. Critical Reviews in Oncology/Hematology. 165. 103431–103431. 13 indexed citations

Campochiaro, Corrado, Nicola Farina, Alessandro Tomelleri, et al.. (2021). Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series. European Journal of Internal Medicine. 93. 87–94. 55 indexed citations

Gebbia, Vittorio, et al.. (2021). Immunotherapeutic Advances for NSCLC. Biologics. Volume 15. 399–417. 17 indexed citations

10.

Mirabile, Aurora, Licia Rivoltini, Elena Daveri, et al.. (2020). Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence. Cancers. 12(5). 1153–1153. 4 indexed citations

11.

Carretta, Angelo, Alessandro Bandiera, Piergiorgio Muriana, et al.. (2020). Prognostic role of positron emission tomography and computed tomography parameters in stage I lung adenocarcinoma. Radiology and Oncology. 54(3). 278–284. 6 indexed citations

12.

Lazzari, Chiara, Greta Grassini, Emanuela Brunetto, et al.. (2019). Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patients. Lung Cancer. 134. 225–232. 13 indexed citations

13.

Rosell, Rafael, Imane Chaib, Niki Karachaliou, et al.. (2017). OA10.03 YAP-NOTCH and STAT3 Signaling Rebound as a Compensatory Response to Gefitinib or Osimertinib Treatment in EGFR Mutant Lung Cancer. Journal of Thoracic Oncology. 12(1). S281–S282. 1 indexed citations

14.

Verlicchi, Alberto, Niki Karachaliou, Chiara Lazzari, et al.. (2016). 72P Differential expression profile of lung squamous cell carcinoma (LSCC) cell lines as a mean to predict drug interaction effects. Journal of Thoracic Oncology. 11(4). S85–S86. 1 indexed citations

15.

Gainor, Justin F., Daniel Shao-Weng Tan, Benjamin Solomon, et al.. (2015). Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib. Clinical Cancer Research. 21(12). 2745–2752. 135 indexed citations

16.

Lazzari, Chiara, Andrea Prodosmo, Francesca Siepi, et al.. (2011). HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage. Oncogene. 30(48). 4802–4813. 43 indexed citations

17.

Lazzari, Chiara, Anna Spreafico, Angela Bachi, et al.. (2011). Changes in Plasma Mass-Spectral Profile in Course of Treatment of Non-small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Journal of Thoracic Oncology. 7(1). 40–48. 33 indexed citations

18.

Bon, Giulia, Selene E. Di Carlo, Valentina Folgiero, et al.. (2009). Negative Regulation of β4 Integrin Transcription by Homeodomain-Interacting Protein Kinase 2 and p53 Impairs Tumor Progression. Cancer Research. 69(14). 5978–5986. 44 indexed citations

19.

Iacovelli, Stefano, Chiara Lazzari, Giorgia Bracaglia, et al.. (2009). HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage. Cell Proliferation. 42(3). 373–384. 33 indexed citations

20.

Lazzari, Chiara, Silvia Truffa, Annalisa Antonini, et al.. (2009). Homeodomain Interacting Protein Kinase 2 Activation Compromises Endothelial Cell Response to Laminar Flow: Protective Role of p21waf1,cip1,sdi1. PLoS ONE. 4(8). e6603–e6603. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact